Multaq Lawsuits: Heart Failure, Kidney Failure
Approved by the U.S. Food and Drug Administration in July 2009, Multaq (dronedarone) is a prescription medicine used to keep the heart beating normally in people with irregular heart rhythm.
Developed by Sanofi-Aventis, Multaq was designed to be a safer antiarrhythmic drug than its predecessor, amiodarone, and is most commonly used to treat disorders of the atrium — called atrial fibrillation (AFib) or atrial flutter. It is also given to reduce the need for hospitalization due to diabetes, high blood pressure, a history of stroke or being over 70 years old.
An estimated one million prescriptions for Multaq were dispensed between July 2009 and June 2011, and approximately 241,000 patients filled Multaq prescriptions at retail pharmacies in the United State, according to the FDA. The only recommended dosage of Multaq is 400 mg twice daily in adults.
The most common side effects of Multaq are diarrhea, nausea, abdominal pain, vomiting, and weakness.
Multaq contains a black-box warning — the strictest allowed by law — due to the potential increased risk of death in people with severe heart failure. In 2011, the FDA notified healthcare professionals and patients about the possibility of severe liver injury, including two cases of acute liver failure.
Multaq Complications & Claims
Two independent studies, conducted by Sanofi-Aventis, found high death rates in certain patients, which has cast serious doubt about the drug’s future.
In 2011, the European Medicines Agency (EMA) recommended restricting the use of Multaq. The committee stated that because of the increased risk of liver, lung, and cardiovascular adverse events, dronedarone “should only be prescribed after alternative treatment options have been considered.”
Patients currently taking dronedarone should have their treatment reassessed by their physician at their next scheduled visit, according to the EMA.
Multaq has been associated with increased risks of serious side effects, including:
- Acute liver failure
- Interstitial lung disease (ILD)
- Sudden cardiac death
- Blood vessel inflammation
- Systemic embolism (blood clot)
- Hospitalization for heart failure
- Pulmonary toxicity
What Are The Requirements and Criteria For Filing a Multaq Lawsuit?
The requirements for filing a lawsuit against Sanofi-Aventis, the manufacturer of Multaq, include:
- Severe liver failure or injury, requiring hospitalization*
- Liver transplant
- Death with liver failure — identified as primary or secondary cause of death
- No pre-exisiting history of severe liver injury or hepatic dysfunction
- Concurrent use of Multaq at the time of diagnosis**
* Visitation to a physician’s office is not considered hospitalization.
**Elevated liver labs (example: ALT, AST, SGoT) alone are not sufficient for inclusion.
Our Multaq Lawyers Can Help You
Our dangerous drug lawyers can help if you or someone you care about was harmed as a result of taking Multaq. Lawsuits have been filed against the drug manufacturer for failure to adequately research their medication or warn about the risk of health problems. Both patients and their families are seeking compensation for injuries. You may be entitled to a settlement if you were harmed by Multaq.
Our No-Fee Promise On Multaq Cases
You can afford to have our great team of Multaq lawyers on your side. If you choose us, it literally costs you nothing to get started. We promise you in writing:
- No money to get started
- We pay all case costs and expenses
- No legal fees whatsoever unless you receive a Multaq settlement
- Phone calls are always free
Start Your Multaq Claim
Our Multaq drug lawyers will help you file your lawsuit. To get started, you can:
- Submit the Free Case Review Box on this page, or
- Call (866) 280-4722 any time of day to tell us about your case.
We will listen to your story and answer your questions. If you have a claim, we will start immediately.
WARNING: There are strict time deadlines for filing Multaq lawsuit claims.